Source: Eur Respir Monogr 2022; 96: 337-349



Rating:

Share or cite this content

Citations should be made in the following way:
Timothy Tully, Marc A. Judson, Amit Suresh Patel, Surinder S. Birring. Quality-of-life assessment in patients with sarcoidosis. Eur Respir Monogr 2022; 96: 337-349

Member's Comments

No comment yet.

Related content which might interest you: Clinical evaluation and follow-up of patients with ILD Source: International Congress 2014 – MS01 Interdisciplinary diagnosis and evaluation of interstitial lung disease Year: 2014 Radiologic assessment of patients with mild COPD before and after the treatment Source: Eur Respir J 2004; 24: Suppl. 48, 68s Year: 2004 Assessment of quality of life in patients with sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 97s Year: 2006 Fatigue perception and related factors in patients with advanced sarcoidosis and COPD patients Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 Physiological measures in the assessment of emphysema in patients diagnosed with COPD in primary care Source: Eur Respir J 2003; 22: Suppl. 45, 385s Year: 2003 Importance of fatigue measurement in sarcoidosis patients Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011 Outcome predictive factors in patients with sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 Comparisons among various QOL assessments and clinical outcomes for one year in elderly patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 66s Year: 2004 Assessment of cardiac involvement in patients with sarcoidosis Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Validity of COPD diagnosis in Bronchiectasis patients: data from the EMBARC registry Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) Year: 2018 Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 Clinical features and outcomes of patients with myositis associated-interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Long-term follow-up of patients with pulmonary sarcoidosis Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Agreement between clinical and HRCT diagnoses in the evaluation of patients with respiratory diseases Source: Annual Congress 2011 - Vascular and parenchymal imaging Year: 2011 Pulmonary evaluation of the patients with psoriasis Source: Eur Respir J 2001; 18: Suppl. 33, 151s Year: 2001 Pulmonary rehabilitation outcome in COPD patients Source: Annual Congress 2003 - Outcome of pulmonary rehabilitation Year: 2003 Clinical assessment and staging of COPD exacerbations Source: International Congress 2014 – PG04 Update on COPD exacerbations Year: 2014 Walking for the assessment of patients with COPD Source: Eur Respir Monogr 2018; 80: 175-195 Year: 2018 Patient-reported distress can aid clinical decision-making in idiopathic pulmonary fibrosis: analysis of the PROFILE cohort Source: Eur Respir J, 53 (5) 1801925; 10.1183/13993003.01925-2018 Year: 2019 GOLD assessment of COPD patients: Impact of symptoms assessment choice Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012